Tumor Landscapes: β-Catenin Drives Immune Desertification
- PMID: 30837277
- DOI: 10.1158/1078-0432.CCR-19-0188
Tumor Landscapes: β-Catenin Drives Immune Desertification
Abstract
Immune checkpoint blockade therapy requires a preestablished activated immune landscape. Understanding tumor-intrinsic mechanisms that lead to T-cell desertification is key to resensitizing them to such therapies. The WNT/β-catenin tumor-intrinsic signaling is emerging as an immune exclusion pathway that holds high promise to counteract resistance to immunotherapy.See related article by Luke et al., p. 3074.
©2019 American Association for Cancer Research.
Comment on
-
WNT/β-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers.Clin Cancer Res. 2019 May 15;25(10):3074-3083. doi: 10.1158/1078-0432.CCR-18-1942. Epub 2019 Jan 11. Clin Cancer Res. 2019. PMID: 30635339 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
